Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trial
Objective Serum calprotectin appears to be an interesting biomarker associated with renal vascular disease activity in antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). The aim of this study was to assess whether serum calprotectin levels can predict decline in renal function in...
Saved in:
Main Authors: | Xavier Romand, Benjamin Terrier, Athan Baillet, Philippe Gaudin, Loic Guillevin, Christian Pagnoux, Minh Vu Chuong, Marie Hélène Paclet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-10-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/4/e003477.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virus-induced Systemic Vasculitides: New Therapeutic Approaches
by: Loïc Guillevin
Published: (2004-01-01) -
ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
by: Marco Folci, et al.
Published: (2019-01-01) -
Gender and Ocular Manifestations of Connective Tissue Diseases and Systemic Vasculitides
by: Maria M. Choudhary, et al.
Published: (2014-01-01) -
The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review
by: Rossella Talotta, et al.
Published: (2017-01-01) -
Serum Calprotectin: A Potential Biomarker for Neonatal Sepsis
by: Lidia Decembrino, et al.
Published: (2015-01-01)